Sector: Health Care
Director information for PHREESIA INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Chaim Indig | CEO, Director; Chief Executive Officer and Director | 47 | ["Founder and Chief Executive Officer of Phreesia","Co-founded the Company in 2005","Led growth from an early-stage startup to a publicly traded healthcare SaaS platform","Recognized as one of The Software Report’s Top 50 SaaS CEOs","Expertise in digital patient access, engagement and payments","Developed healthcare technology commercialization experience","Understanding of provider economics and revenue cycle management","Experience in public company leadership"] | [] | 2026 |
| Ed Cahill | [] | ["Compensation Committee"] | 2026 | ||
| Gillian Munson | Independent Director | 55 | ["Seasoned public company CFO with more than 30 years of operating leadership","CFO roles at Vimeo, Iora Health and XO Group","Significant audit and financial reporting expertise","Experience managing financial reporting and compliance demands","Background as a former investment banker and equity analyst","Extensive experience with transformative M&A, capital allocation and capital markets","B.A. in Political Science and Economics from The Colorado College","Software Industry Experience","Healthcare Industry Experience","Public Company Director Experience (non-Phreesia)","Senior Business Executive Experience","Financial Statements and Accounting Experience","Privacy/Data Security Experience"] | ["Audit Committee","Compensation Committee"] | 2026 |
| Jon Kessler | Independent Director | 58 | ["Experienced public company CEO","Leader in healthcare technology and financial services","Oversaw HealthEquity's IPO on Nasdaq","Founded WageWorks","Extensive public company capital markets, M&A, finance and governance experience","Expertise in benefits and taxation","Audit committee financial expert under SEC regulations","Experience with cybersecurity reviews and regulatory matters","Former Benefits Taxation Specialist at Arthur Andersen","Senior Economist during Clinton and Bush administrations","Software Industry Experience","Healthcare Industry Experience","Public Company Director Experience (non-Phreesia)"] | [] | 2026 |
| Lainie Goldstein | Independent Director | 58 | ["Current public company CFO with operations leadership ability","Led finance, accounting, tax, treasury, investor relations and corporate communications at Take-Two Interactive Software","Extensive involvement with transformative M&A, integration and strategic planning","Deep financial, accounting and technology risk expertise","Instilled strong fiscal discipline through cost-reduction programs","Qualifies as an audit committee financial expert under SEC regulations","Holds a BSBA in Accounting from The American University","Experienced in cybersecurity, digital infrastructure, and trust and safety","Software Industry Experience","Public Company Director Experience (non-Phreesia)","Senior Business Executive Experience","Financial Statements and Accounting Experience"] | ["Compensation Committee"] | 2026 |
| Lisa Egbuonu-Davis | ["Healthcare Industry Experience","Public Company Director Experience (non-Phreesia)"] | [] | 2026 | ||
| Lisa Egbuonu-Davis, M.D. | Independent Director | 68 | ["Senior operating executive across the healthcare ecosystem","Former Vice President, Medical Innovations for Danaher’s diagnostics platform","Experience in leadership roles at Pfizer","Deep experience driving patient-centered outcomes and engagement","Expertise in regulatory and compliance matters in healthcare services and MedTech sectors","MBA in Health Care Management from The Wharton School","Doctor of Medicine and Master of Public Health degrees from Johns Hopkins University","Board certified in pediatrics"] | ["compensation","nominating and governance","compliance","Compensation Committee"] | 2026 |
| Mark Smith | ["Software Industry Experience","Healthcare Industry Experience","Public Company Director Experience (non-Phreesia)"] | [] | 2026 | ||
| Mark Smith, M.D. | Independent Director | 74 | ["Nationally recognized health policy leader","Substantial executive leadership experience","Founding President and CEO of the California HealthCare Foundation","Expertise in healthcare quality, delivery reform and innovation","Led national initiatives focused on healthcare payment transformation","Broad governance experience across public companies and nonprofit organizations","Clinical Professor of Medicine, University of California at San Francisco","Co-Chair, Health Care Payment Learning and Action Network","Other Board Experience including Teladoc and Jazz Pharmaceuticals"] | ["Audit Committee"] | 2026 |
| Michael Weintraub | [] | ["Audit Committee","Compensation Committee"] | 2026 | ||
| Ramin Sayar | Independent Director | 53 | ["Public company CEO experience across the full organization lifecycle","Proven SaaS operator","Leadership in growing annual revenue from $10 million to over $300 million","Led successful IPO in 2020","Executed a strategic sale to private equity at a 57% premium for $1.7 billion","Experience operating a technology company across venture, growth-stage and public company scale","Insights into evolving technology trends impacting platforms and strategy","Capital markets and governance experience","Led IPO preparation, public company reporting and investor engagement","Oversaw significant strategic M&A transactions","Board governance and risk oversight experience","Holds a B.A. in History and an M.B.A.","Software Industry Experience","Healthcare Industry Experience","Public Company Director Experience (non-Phreesia)","Senior Business Executive Experience"] | ["Compensation Committee"] | 2026 |
